Byrne H, OReilly S, Weadick C, Brady P, Riordain R
Eur J Med Res. 2024; 29(1):402.
PMID: 39095845
PMC: 11297747.
DOI: 10.1186/s40001-024-01912-6.
Assari A, Alanazi Y, Mubarak Algharbi E, Abuhabsha A, Alshammry B, Alzahrani A
Cureus. 2024; 16(1):e52896.
PMID: 38406100
PMC: 10891455.
DOI: 10.7759/cureus.52896.
Choi S, Kim J, Oh S, Cheon S, Yee J, Kim S
Front Med (Lausanne). 2023; 10:1140620.
PMID: 37415765
PMC: 10321771.
DOI: 10.3389/fmed.2023.1140620.
Roato I, Mauceri R, Notaro V, Genova T, Fusco V, Mussano F
Int J Mol Sci. 2023; 24(9).
PMID: 37175652
PMC: 10177780.
DOI: 10.3390/ijms24097948.
Saadi S, Moreno-Rabie C, Van den Wyngaert T, Jacobs R
Bone Rep. 2022; 17:101632.
PMID: 36389628
PMC: 9640953.
DOI: 10.1016/j.bonr.2022.101632.
Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction.
Moreno-Rabie C, Lapauw L, Gaeta-Araujo H, Ferreira-Leite A, Coucke W, Van den Wyngaert T
Sci Rep. 2022; 12(1):11280.
PMID: 35789184
PMC: 9252989.
DOI: 10.1038/s41598-022-15254-y.
The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists.
Mauceri R, Coniglio R, Abbinante A, Carcieri P, Tomassi D, Panzarella V
Support Care Cancer. 2022; 30(8):6429-6440.
PMID: 35292850
PMC: 9213300.
DOI: 10.1007/s00520-022-06940-8.
Effects of Soft Tissue Closure on Medication-Related Osteonecrosis of the Jaw in a Rabbit Model with Tooth Extraction: A Pilot Study.
Yu R, Li J, Wang J, Huo L, Zheng L
Biomed Res Int. 2021; 2021:4166770.
PMID: 34957304
PMC: 8694973.
DOI: 10.1155/2021/4166770.
CD34 and CD105 Microvessels in Resected Bone Specimen May Implicate Wound Healing in MRONJ.
Marciano A, Ieni A, Mauceri R, Oteri G
Int J Environ Res Public Health. 2021; 18(21).
PMID: 34769880
PMC: 8582901.
DOI: 10.3390/ijerph182111362.
Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset.
Marciano A, Ingrasciotta Y, Isgro V, LAbbate L, Foti S, Picone A
J Clin Med. 2021; 10(20).
PMID: 34682884
PMC: 8537110.
DOI: 10.3390/jcm10204762.
Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review.
Lorenzo-Pouso A, Bagan J, Bagan L, Gandara-Vila P, Chamorro-Petronacci C, Castelo-Baz P
J Clin Med. 2021; 10(19).
PMID: 34640383
PMC: 8509366.
DOI: 10.3390/jcm10194367.
A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva) Related Osteonecrosis of the Jaw: A Retrospective Study.
Assili Z, Dolivet G, Salleron J, Griffaton-Tallandier C, Egloff-Juras C, Phulpin B
J Clin Med. 2021; 10(11).
PMID: 34071481
PMC: 8197814.
DOI: 10.3390/jcm10112390.
Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).
Otto S, Aljohani S, Fliefel R, Ecke S, Ristow O, Burian E
Medicina (Kaunas). 2021; 57(5).
PMID: 34065104
PMC: 8151678.
DOI: 10.3390/medicina57050463.
Comments on " Cutaneous Abscess as a Complication of Bisphosphonate-Related Osteonecrosis of the Jaw " by Yang et al.
Hakamifard A
Ann Dermatol. 2021; 31(4):492-493.
PMID: 33911639
PMC: 7992744.
DOI: 10.5021/ad.2019.31.4.492.
A critical assessment of the medication-related osteonecrosis of the jaw classification in stage I patients: a retrospective analysis.
Ristow O, Hurtgen L, Moratin J, Smielowski M, Freudlsperger C, Engel M
J Korean Assoc Oral Maxillofac Surg. 2021; 47(2):99-111.
PMID: 33911042
PMC: 8084747.
DOI: 10.5125/jkaoms.2021.47.2.99.
Human amniotic membrane: an improvement in the treatment of Medication-related osteonecrosis of the jaw (MRONJ)? A case-control study.
Ragazzo M, Val M, Montagner G, Trojan D, Fusetti S, Guarda Nardini L
Cell Tissue Bank. 2021; 23(1):129-141.
PMID: 33856589
PMC: 8854299.
DOI: 10.1007/s10561-021-09922-y.
A New Medical Record Proposal to the Prognostic Risk Assessment for MRONJ in Oncologic Patients: "Sapienza Head and Neck Unit" Proposal.
Brauner E, Mezi S, Ciolfi A, Ciolfi C, Pucci R, Cassoni A
Int J Environ Res Public Health. 2021; 18(4).
PMID: 33672876
PMC: 7918934.
DOI: 10.3390/ijerph18041851.
Several issues regarding the diagnostic imaging of medication-related osteonecrosis of the jaw.
Kim J, Yoo S, Choi S
Imaging Sci Dent. 2021; 50(4):273-279.
PMID: 33409135
PMC: 7758260.
DOI: 10.5624/isd.2020.50.4.273.
Medication-Related Osteonecrosis of the Jaws and CDK4/6 Inhibitors: A Recent Association.
Marciano A, Guzzo G, Peditto M, Picone A, Oteri G
Int J Environ Res Public Health. 2020; 17(24).
PMID: 33353034
PMC: 7767118.
DOI: 10.3390/ijerph17249509.
A multicenter observational study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in advanced cancer and myeloma patients of a cancer network in North-Western Italy.
Fusco V, Cabras M, Erovigni F, DellAcqua A, Arduino P, Pentenero M
Med Oral Patol Oral Cir Bucal. 2020; 26(4):e466-e473.
PMID: 33340073
PMC: 8254890.
DOI: 10.4317/medoral.24318.